Kian Pee Wan Capsules — Class I drug recall D-0769-2026
Ongoing recall by Buy-Herbal, reported 2026-08-19. Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyprohep
| Recall number | D-0769-2026 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Buy-Herbal, Flushing, NY, United States |
| Recall initiated | 2026-03-21 |
| Classified | 2026-08-17 |
| Reported by FDA | 2026-08-19 |
| Quantity | 71 bottles |
| Reason classes | undeclared allergen, unapproved product |
Product
Kian Pee Wan Capsules, 30-count bottles
Reason for recall
Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0769-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.